Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
5 Top Health Care Stocks To Watch In The Stock Market Today
01:00pm, Sunday, 03'rd Apr 2022
Are these health care stocks on your watchlist right now?
Novavax (NVAX) Seeks EU Nod for COVID-19 Vaccine in Kids
05:09pm, Friday, 01'st Apr 2022 Zacks Investment Research
Novavax (NVAX) seeks label expansion for its COVID-19 vaccine in adolescents aged 12-17 years in the European Union. Currently, the vaccine is authorized for use in adults.
3 Top Health Care Stocks To Watch Today
04:30pm, Friday, 01'st Apr 2022
Could these health care stocks be healthy additions to your portfolio?
Biden says U.S. turning corner on COVID, but experts are worried that BA.2 is pushing cases higher in 15 states
10:38am, Friday, 01'st Apr 2022 MarketWatch
President Joe Biden said Wednesday the U.S. is turning the page on the COVID-19 pandemic, as his administration took the wraps off a website that aims to help Americans find tests, treatments and othe
Why Novavax Stock Dipped On Thursday
10:19pm, Thursday, 31'st Mar 2022 The Motley Fool
Two outwardly positive developments for the company weren't enough to prevent a minor investor sell-off.
Company News for Mar 31, 2022
01:37pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Companies In The News Are: FIVE, MSM, BNTX, AER.
BioNTech gibt Rückkaufprogramm für American Depositary Shares (ADS) bekannt
11:00am, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
MAINZ, Deutschland, 31. März 2022 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) hat heute bekannt gegeben, ein Aktienrückkaufprogramm („das Programm") a
BioNTech Announces ADS Repurchase Program
11:00am, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
MAINZ, Germany, March 31, 2022 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) today announced that it has entered into a share repurchase program (the “Program�
BioNTech SE (BNTX) Q4 2021 Earnings Call Transcript
12:00am, Thursday, 31'st Mar 2022 The Motley Fool
BNTX earnings call for the period ending December 31, 2021.
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
02:15pm, Wednesday, 30'th Mar 2022 The Motley Fool
The company gives investors plenty of reasons to buy and hold the stock for years.
FDA Authorizes Pfizer, Moderna's Second COVID Booster Dose
01:18pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
The FDA authorized a second booster dose of COVID-19 vaccines made by Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) for older adults and some immunocompromised individuals.
U.S. average daily deaths from COVID fall below 800 to lowest level since mid-August, and FDA allows second booster shot for people 50 and older
11:49am, Wednesday, 30'th Mar 2022 MarketWatch
The average number of daily deaths from COVID-19 in the U.S. has fallen below 800 for the first time since the highly transmissible omicron variant was first detected in the fall, and is now trending
BioNTech SE (BNTX) CEO Ugur Sahin on Q4 2021 Results - Earnings Call Transcript
10:29am, Wednesday, 30'th Mar 2022
BioNTech SE (BNTX) CEO Ugur Sahin on Q4 2021 Results - Earnings Call Transcript
A Peek Into The Markets: US Stock Futures Down Ahead Of GDP Report
10:05am, Wednesday, 30'th Mar 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped more than 300 points in the previous session. Investors are awaiting earnings results from Five Be
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
10:00am, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
Conference call and webcast scheduled for March 30, 2022 at 8:00 am ET (2:00 pm CET)
